Research programme: estrogen receptor agonists - Organon

Drug Profile

Research programme: estrogen receptor agonists - Organon

Alternative Names: ORG 239235; ORG 41749; ORG 50426

Latest Information Update: 16 Nov 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Organon
  • Class
  • Mechanism of Action Estrogen receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Female genital diseases; Menopausal syndrome

Most Recent Events

  • 07 Dec 2007 Preclinical development is ongoing
  • 19 Nov 2007 Organon has been acquired by Schering-Plough
  • 31 Dec 2006 Preclinical trials in Menopausal syndrome in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top